The corresponding RMST for placebo was 3.00 years. The difference of 0.07 years (95% CI, 0.03–0.11; P=0.0016) was highly statistically significant in favor of candesartan. This example demonstrates ...

This is the source code for the RMSTSens package in R. RMSTSens is a package aimed at providing a novel sensitivity analysis method for the RMST difference when unmeasured confounding is suspected.

RMST differences between different characteristics of patients with other risk factors in control can be interpreted as the number of months lost due to this characteristic. mRS ≥3 thus resulted in ...

# This is a copy of the R script used to generate the figures for, and perform the statistical analysis on, # the Restricted Mean Survival Time (RMST) data from Experiments 1-4 that is reported in ...

The 48-month survival difference was 37.8% (95% confidence interval [CI] 19.8 to 60.5), and the corresponding restricted mean survival time difference 8.3 months (95% CI: 4.1 to 12.7). The 12-month ...

"But there's a catch: RMST can test differences in a treatment's effect between groups from baseline to a time point -- the threshold -- but identifying the ideal threshold in clinical and ...

The difference of 0.50 years (95% CI, 0.13–0.86; P=0.01) also significantly favored new generation stents. In general, RMST procedures do not result in any power loss versus HR, and beyond the ...

Department of Statistics and Actuarial Science, The University of Hong Kong, China (G.Y.). An alternative is to use the difference in RMSTs to quantify the treatment effect. RMST is the average ...